Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trihexyphenidyl in Children With Dystonic Cerebral Palsy
NCT06554288Phase 1Recruiting
- Sponsor
- Children's Mercy Kansas City
- Start
- Oct 2024
- Primary completion
- Nov 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of trihexyphenidyl in dystonic cerebral palsy, sponsored by Children's Mercy Kansas City. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from time zero to time n and 4 more. Started Oct 2024; status: recruiting.
02
Drugs
trihexyphenidyl
03
Conditions
dystonic cerebral palsy
Beyond the preview
Go deeper on NCT06554288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06554288.